Ultimovacs ASA: Notice of Annual General Meeting on April 18, 2024
25 Mar 2024
Ultimovacs ASA: Notice of Annual General Meeting on April 18, 2024
Oslo, March 25, 2024, the Board of Directors hereby calls for the Annual General Meeting of Ultimovacs ASA (the "Company") at 14:00 CET on April 18, 2024.
The General Meeting will be held electronically. For participation, please log in at https://dnb.lumiagm.com/137559337. All documents regarding the Annual General Meeting are available at the Company’s website: www.ultimovacs.com
For further information, please see www.ultimovacs.com or contact:
Jónas Einarsson, Chairman of the Board of Directors of Ultimovacs ASA
Email: je@radforsk.no
Phone: +47 480 96355
Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com
Phone: +47 908 92507
Anne Worsøe, Head of Investor Relations and ESG
Email: anne.worsoe@ultimovacs.com
Phone: +47 906 86815
Attachments
Ultimovacs ASA Notice of Annual General Meeting 2024
Appendix 1 - Registration and proxy form to the Annual General Meeting
Appendix 2 - Financial Statements 2023
Appendix 3 - Remuneration Guidelines 2024
Appendix 4 - Remuneration Report 2023
Appendix 5 - Recommendations by the Nomination Committee 2023
Appendix 6 - Updated Articles of Association
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.